Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/28/23 17:17  | 6/27/23  | ALVR | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 10,991 | 3.75 | 0 | 2,931 | 21 | 16,635 | D | |||||||||||||||
4/28/22 07:46  | 4/26/22  | ALVR | Health | BioPrd | Biological Products, (No Diag | Bornstein Jeffrey S | MA | D | P | 23 | 4.64 | 0 | 5 | 14 | 40 | D | |||||||||||||||
2/10/22 17:03  | 2/10/22  | ALVR | Health | BioPrd | Biological Products, (No Diag | Bornstein Jeffrey S | MA | D | P | 44 | 8.87 | 0 | 5 | 17 | 35 | D | |||||||||||||||
8/6/20 06:06  | 8/3/20  | ALVR | Health | BioPrd | Biological Products, (No Diag | Jovan-Embiricos Morana | MA | DT | P.d | 49,300 | 17.00 | 0 | 2,900 | 2,830 | I | ||||||||||||||||
8/5/20 21:55  | 8/3/20  | ALVR | Health | BioPrd | Biological Products, (No Diag | Van Beek Jeroen B | MA | O | Chief Co | P.d | 51 | 17.00 | 0 | 3 | 1 | 525 | D | ||||||||||||||
8/5/20 21:42  | 8/3/20  | ALVR | Health | BioPrd | Biological Products, (No Diag | Brainard Diana | MA | D | P | 107 | 17.00 | 0 | 6 | New | 6 | D | |||||||||||||||
8/5/20 21:39  | 8/3/20  | ALVR | Health | BioPrd | Biological Products, (No Diag | Atillasoy Ercem | MA | O | See Rema | P | 60 | 17.00 | 0 | 4 | 5 | 79 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |